1. Liu, Xuanyu, Zeng, Qingyi, Yang, Hang, Shu, Chang, Zhou, Zhou. 2024. Single-Nucleus Multiomic Analyses Identifies Gene Regulatory Dynamics of Phenotypic Modulation in Human Aneurysmal Aortic Root. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2400444. doi:10.1002/advs.202400444. https://pubmed.ncbi.nlm.nih.gov/38552156/
2. Karanth, Santhosh, Zinkhan, Erin K, Hill, Jonathon T, Yost, H Joseph, Schlegel, Amnon. 2016. FOXN3 Regulates Hepatic Glucose Utilization. In Cell reports, 15, 2745-55. doi:10.1016/j.celrep.2016.05.056. https://pubmed.ncbi.nlm.nih.gov/27292639/
3. Yu, Wei, Diao, Yongkang, Zhang, Yi, Huang, Dongsheng, Zhang, Jungang. 2022. Bioinformatic analysis of FOXN3 expression and prognostic value in pancreatic cancer. In Frontiers in oncology, 12, 1008100. doi:10.3389/fonc.2022.1008100. https://pubmed.ncbi.nlm.nih.gov/36324573/
4. Karanth, Santhosh, Chaurasia, Bhagirath, Bowman, Faith M, Summers, Scott A, Schlegel, Amnon. . FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection. In Physiological reports, 7, e14238. doi:10.14814/phy2.14238. https://pubmed.ncbi.nlm.nih.gov/31552709/
5. Erickson, Melissa L, Karanth, Santhosh, Ravussin, Eric, Schlegel, Amnon. 2019. FOXN3 hyperglycemic risk allele and insulin sensitivity in humans. In BMJ open diabetes research & care, 7, e000688. doi:10.1136/bmjdrc-2019-000688. https://pubmed.ncbi.nlm.nih.gov/31543974/
6. Yang, Hua, Li, Mingyu, Qi, Yue. 2023. FOXN3 inhibits the progression of ovarian cancer through negatively regulating the expression of RPS15A. In Human cell, 36, 1120-1134. doi:10.1007/s13577-023-00876-9. https://pubmed.ncbi.nlm.nih.gov/37016167/
智鼠故事 
